Continuous mONitoring of recovery iN acutE isChaemic sTroke - CONNECT
Project Lead
Dr Xiaoying Chen, The George Institute Australia
Project Team
Prof Craig Anderson, TGI; Dr Candice Delcourt, TGI; Prof Ken Butcher, Prince of Wales Hospital; Dr Kylie Tastula, Royal Alfred Prince Hospital; Dr Xia Wang, TGI; Dr Leibo Liu, TGI; Dr Samuel van Bohemen, Nuroflux
Industry Partner
Nuroflux Pty Ltd
Project Summary
Problem
Acute ischaemic stroke (AIS), resulting from sudden brain vessel blockage, is a leading cause of death and disability. Current monitoring methods rely on intermittent imaging, failing to detect subtle neurological deterioration early, particularly in patients with large-vessel occlusion (LVO).
Solution
The CONNECT project proposes to assess the Nuroflux device, capable of continuous monitoring of brain activity and cerebral blood flow (CBF). This single-site feasibility study aims to validate the device’s efficacy in detecting early signs of neurological decline in AIS patients, enhancing timely interventions and patient outcomes.
Impact
By enabling real-time monitoring, the Nuroflux device aims to reduce nursing resources, tailor imaging needs, and improve treatment efficacy. It promises to fill a critical gap in stroke management by providing clinicians with objective data crucial for decision-making during the acute phase. Successful implementation could significantly enhance patient care, potentially reducing long-term disability and healthcare costs associated with stroke in Australia and beyond.
This study, supported by rigorous clinical validation and stakeholder engagement, aligns with national stroke reduction objectives and positions Nuroflux Pty Ltd to advance towards regulatory approvals and commercialisation. The project not only addresses a pressing clinical need but also underscores Australia's potential to lead in innovative MedTech solutions for global healthcare challenges
